DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
168	エーラス・ダンロス症候群	1

告示番号

疾患名（ページ内リンク）

臨床試験数

168

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01307527 (ClinicalTrials.gov)	November 2008	1/3/2011	Riboflavin Corneal Crosslinking for Brittle Cornea Syndrome and Ehlers-Danlos Syndrome Type VI		Brittle Cornea Syndrome;Ehlers-Danlos Syndrome Type 6	Drug: Riboflavin;Device: Kera-X	Hadassah Medical Organization	NULL	Enrolling by invitation	18 Years	N/A	Both	1	N/A	Israel

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

November 2008

1/3/2011

Riboflavin Corneal Crosslinking for Brittle Cornea Syndrome and Ehlers-Danlos Syndrome Type VI

Brittle Cornea Syndrome;Ehlers-Danlos Syndrome Type 6

Drug: Riboflavin;Device: Kera-X

Hadassah Medical Organization

NULL

Enrolling by invitation

18 Years

N/A

Both

N/A

Israel